Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Apr;44(2):130-137.
doi: 10.1007/s00059-019-4795-6.

Key inflammatory pathways underlying vascular remodeling in pulmonary hypertension

Affiliations

Key inflammatory pathways underlying vascular remodeling in pulmonary hypertension

E M Berghausen et al. Herz. 2019 Apr.

Abstract

Independent of the underlying cause, pulmonary hypertension (PH) remains a devastating condition that is characterized by limited survival. Cumulating evidence indicates that in addition to a dysbalance of mediators regulating vascular tone and growth factors promoting vascular remodeling, failure to resolve inflammation and altered immune processes play a pivotal role in the development and progression of PH. Here, we highlight the role of key inflammatory pathways in the pathobiology of vascular remodeling and PH, and discuss potential therapeutic interventions that may halt disease progression or even reverse pulmonary vascular remodeling. Perivascular inflammation is present in all forms of PH, and inflammatory pathways involve numerous mediators and cell types including macrophages, neutrophils, T cells, dendritic cells, and mast cells. Dysfunctional bone morphogenic protein receptor 2 (BMPR2) signaling and dysregulated immunity enable the accumulation of macrophages and other inflammatory cells in obliterative vascular lesions. Regulatory T cells (Tregs) were shown to be of particular relevance in the control of inflammatory responses. Key cytokines/chemokines include interleukin-6, functioning via classic or trans-signaling, macrophage migratory inhibitory factor (MIF), but also other mediators such as neutrophil-derived myeloperoxidase. The expanding knowledge on this topic has resulted in multiple opportunities for sophisticated therapeutic interventions.

Keywords: Chemokines; Cytokines; Immunity; Inflammation; Lung.

PubMed Disclaimer

References

    1. Immunobiology. 2000 Jan;201(3-4):470-7 - PubMed
    1. Nat Med. 2000 Jun;6(6):698-702 - PubMed
    1. Am J Hum Genet. 2000 Sep;67(3):737-44 - PubMed
    1. Nat Genet. 2000 Sep;26(1):81-4 - PubMed
    1. Am J Physiol Lung Cell Mol Physiol. 2001 Jan;280(1):L39-49 - PubMed

LinkOut - more resources